Correlation Between Johnson Johnson and Elicio Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Johnson Johnson and Elicio Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Johnson Johnson and Elicio Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Johnson Johnson and Elicio Therapeutics, you can compare the effects of market volatilities on Johnson Johnson and Elicio Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Johnson Johnson with a short position of Elicio Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Johnson Johnson and Elicio Therapeutics.

Diversification Opportunities for Johnson Johnson and Elicio Therapeutics

-0.64
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Johnson and Elicio is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding Johnson Johnson and Elicio Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elicio Therapeutics and Johnson Johnson is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Johnson Johnson are associated (or correlated) with Elicio Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elicio Therapeutics has no effect on the direction of Johnson Johnson i.e., Johnson Johnson and Elicio Therapeutics go up and down completely randomly.

Pair Corralation between Johnson Johnson and Elicio Therapeutics

Considering the 90-day investment horizon Johnson Johnson is expected to under-perform the Elicio Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Johnson Johnson is 7.61 times less risky than Elicio Therapeutics. The stock trades about -0.01 of its potential returns per unit of risk. The Elicio Therapeutics is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  850.00  in Elicio Therapeutics on August 27, 2024 and sell it today you would lose (357.00) from holding Elicio Therapeutics or give up 42.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Johnson Johnson  vs.  Elicio Therapeutics

 Performance 
       Timeline  
Johnson Johnson 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Johnson Johnson has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively steady basic indicators, Johnson Johnson is not utilizing all of its potentials. The latest stock price chaos, may contribute to medium-term losses for the stakeholders.
Elicio Therapeutics 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Elicio Therapeutics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Elicio Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Johnson Johnson and Elicio Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Johnson Johnson and Elicio Therapeutics

The main advantage of trading using opposite Johnson Johnson and Elicio Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Johnson Johnson position performs unexpectedly, Elicio Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elicio Therapeutics will offset losses from the drop in Elicio Therapeutics' long position.
The idea behind Johnson Johnson and Elicio Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA